Pharmaceutical

NHS rolls out monoclonal antibody treatment for rare bone disease  

The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.

Nov 27, 2024 - 06:00
NHS rolls out monoclonal antibody treatment for rare bone disease  
The NHS will provide the monoclonal antibody Crysvita at 20 specialist centres across England for patients with XLH.
Read the original article

Tags:

Previous Article

Arrowhead and Sarepta link for rare genetic disease treatments

Next Article

Eton acquires US rights to neonatal diabetes treatment from AMMTeK

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

GSK obtains approval in Japan for shingles vaccine

GSK obtains approval in Japan for shingles vaccine

Jun 27, 2023

STAT+: Merck to acquire Prometheus Biosciences, maker of autoimmune drugs, for $10.8 billion

STAT+: Merck to acquire Prometheus Biosciences, maker o...

Apr 17, 2023

Beating the Big C

Beating the Big C

Apr 16, 2023